Therefore, in the present study, we aimed to investigate whether emodin can inhibit the growth of pancreatic cancer cells and the angiogenesis of pancreatic cancer via a possible NF-κB involved mechanism. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.